The largest database of trusted experimental protocols

48 protocols using nunc 96 well plate

1

Measuring Genetic Circuit Performance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Strains harboring genetic circuit were streaked on the LB agar (2%) plate without antibiotics. E. coli MG1655 wild‐type and RPUG standard strains were streaked as controls. Individual colonies were picked from plates and were inoculated into M9 media without antibiotics. Cells were incubated overnight at 37°C and 1,000 rpm in an ELMI plate shaker using Nunc™ 96‐well plates (Thermo Scientific, USA, 249662). The next day, cells were then diluted 185‐fold into 200 μl of fresh M9 media without antibiotics and incubated for three hours at 37°C, 1,000 rpm in an ELMI plate shaker using Nunc™ 96‐well plates (Thermo Scientific, USA, 249662). After three hours, cells were 700‐fold diluted into M9 media without antibiotics and were induced with appropriate combinations of inducers such as 1 mM IPTG, 12.5 mM L‐arabinose, 20 ng/μl aTc, 10 μM OHC14, and 200 μM vanillic acid were used as indicated in Cello 2.0 prediction. After 5.5 h, 30 μl of cells was added to 200 μl 1× PBS with 2 mg/ml Kan for flow cytometry analysis. Median YFP fluorescence from each sample was analyzed using FlowJo (TreeStar, Inc., USA) software and was converted into RPUG.
+ Open protocol
+ Expand
2

Characterizing NOT gate response functions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each strain containing a NOT gate was streaked on the LB agar (2%) plates with Kan (50 μg/ml) and Cm (35 μg/ml) antibiotics. A single colony was picked and inoculated into M9 media with Kan (50 μg/ml) and Cm (35 μg/ml) for overnight culture in an ELMI plate shaker at 37°C and 1,000 rpm. Cell cultures were performed using Nunc™ 96‐well plates (Thermo Scientific, USA, 249662). The next day, cells were 185‐fold diluted into 200 μl fresh M9 media with no antibiotics and incubated for 3 h in an ELMI plate shaker at 37°C and 1,000 rpm. After the 3 h, cells were then diluted again 700‐fold into 200 μl fresh M9 media with no antibiotics and were incubated with inducers for additional 5.5 h in an ELMI plate shaker at 37°C and 1,000 rpm. After the 5.5 h, 30 μl of cells was added to 200 μl 1× PBS with 2 mg/ml Kan for flow cytometry analysis. To measure OD, 150 μl aliquots were transferred to an optically transparent Nunc™ 96‐well plates (Thermo Scientific, USA, 165305) to measure OD600 using a Hybrid Microplate Reader BioTek Synergy H1 (BioTek Instruments Inc, USA). To measure the gate response functions, input and output promoter activities measured as median YFP fluorescence were converted into RPUG. The response functions were fit to a Hill equation y = ymin + ((ymax − ymin)/(1 + (x/K)n), using an in‐house Python script.
+ Open protocol
+ Expand
3

Cytokine Profiling in Lacrimal Glands

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lacrimal glands were homogenized as described above and the supernatants (Si) were used to determine the levels of cytokines IL-1β, TNF-α, IFN-γ, IL-10, and IL-4 using the BD OptEIA ELISA sets (BD Biosciences, San Jose, CA). Sandwich ELISAs were performed according to the manufacturer’s instructions using Nunc 96-well plates (Fisher Scientific, Suwanee, GA). The concentration of protein used was 30 μg per well. The OD values for each sample were obtained by measuring the absorbance at 450 nm in a microplate reader (Molecular devices, CA, USA). Mouse cytokines provided by the manufacturer were used as positive controls. The concentrations in pg/ml were obtained by using the standards provided by the manufacturer.
+ Open protocol
+ Expand
4

Culturing Patient-Derived Leukemia Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient derived leukemia cells were cultured on MS5 stromal cells in the presence of 50 ng/mL recombinant human stem cell factor (SCF), 50 ng/mL recombinant human thrombopoietin (TPO), 10 ng/mL recombinant human FLT3 ligand (FLT3L), and 10 ng/mL recombinant human interleukin-7 (IL-7, all from R and D Systems) in Myelocult H5100 (Stem Cell Technologies) supplemented with 1% penicillin/streptomycin (Issaad et al., 1993 (link)) with modifications based on (Doulatov et al., 2010 (link)) to facilitate lymphoid cell growth; i.e., without horse serum or hydrocortisone (Issaad et al., 1993 (link)). Leukemia 1/MLL-AF4 was most amenable to in vitro culture and so was used for most culture-based experiments. For in vitro LDA experiments, 5,000 MS5 cells were plated in wells of gelatin-coated Nunc 96 well plates (Fisher Scientific) with cytokines 48 hours prior to FACS-based sorting of leukemia cells directly into the wells.
Human MV4; 11 and RS4; 11 cells (ATCC) were cultured in RPMI with 10% fetal calf serum supplemented with penicillin and streptomycin.
As indicated in Table S1, some specimens were subjected to focused somatic mutation analysis (Rapid Heme Panel (Kluk et al., 2016 (link))).
+ Open protocol
+ Expand
5

Culturing Patient-Derived Leukemia Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient derived leukemia cells were cultured on MS5 stromal cells in the presence of 50 ng/mL recombinant human stem cell factor (SCF), 50 ng/mL recombinant human thrombopoietin (TPO), 10 ng/mL recombinant human FLT3 ligand (FLT3L), and 10 ng/mL recombinant human interleukin-7 (IL-7, all from R and D Systems) in Myelocult H5100 (Stem Cell Technologies) supplemented with 1% penicillin/streptomycin (Issaad et al., 1993 (link)) with modifications based on (Doulatov et al., 2010 (link)) to facilitate lymphoid cell growth; i.e., without horse serum or hydrocortisone (Issaad et al., 1993 (link)). Leukemia 1/MLL-AF4 was most amenable to in vitro culture and so was used for most culture-based experiments. For in vitro LDA experiments, 5,000 MS5 cells were plated in wells of gelatin-coated Nunc 96 well plates (Fisher Scientific) with cytokines 48 hours prior to FACS-based sorting of leukemia cells directly into the wells.
Human MV4; 11 and RS4; 11 cells (ATCC) were cultured in RPMI with 10% fetal calf serum supplemented with penicillin and streptomycin.
As indicated in Table S1, some specimens were subjected to focused somatic mutation analysis (Rapid Heme Panel (Kluk et al., 2016 (link))).
+ Open protocol
+ Expand
6

HBV Epsilon RNA Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A fixed concentration of HBV ε RNA (500 nM) and SYBRG II (Invitrogen) (4x) was used. 5 μL of compound (in DMSO) and 95 μL of RNA/dye complex in assay buffer D (5 mM sodium cacodylate pH 6.5, 50 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 0.01% Triton-X100) were added to black Nunc 96-well plates (Fisher Scientific), incubated at room temperature for 30 min and fluorescence intensity values were measured (485 ± 5 nm excitation, 525 ± 5 nm emission) using a Tecan plate reader. Kd values were determined by normalizing fluorescence intensity of each well to an average value for the fluorescence intensity of RNA/dye complex (GraphPad Prism 7.0 software). Errors in Kd values are reported as the standard error of triplicate experiments.
+ Open protocol
+ Expand
7

Osteogenic Differentiation of MSC Subpopulations

Check if the same lab product or an alternative is used in the 5 most similar protocols
AD-MSC lines were washed with PBS and stained with ALP-APC (R&D) (1/50) and CD73-FITC (Biolegend) (1/160) for 25 min at 4 °C. Upon washing, the cell fractions (controls sorted, ALP+/CD73+, ALP−/CD73high, ALP−/CD73low) were sorted with a FACS BD Aria III 5L and seeded in Nunc™ 96-well plates (TPP) at a density of 1.2 × 104 cells/cm2 for osteogenic differentiation. Controls sorted were unstained cells processed through the FACS and collected without sorting specific subpopulations. Differentiation was induced 24 h after seeding. Freshly isolated SVFs were washed with PBS and stained with ALP-APC (R&D) (1/50), CD73-FITC (Biolegend) (1/160), and CD45-PE (Biolegend) (1/160) for 25 min at 4 °C. SVF fractions (controls sorted, CD45−/ALP+/CD73+, CD45−/ALP−/CD73high, CD45−/ALP−/CD73low) were sorted with FACS BD Aria III 5L and plated in vitro at a density of 1 × 104 in 96-well plates (TPP) for osteogenic differentiation. All media were changed every 4 days.
+ Open protocol
+ Expand
8

Cytotoxicity Assay with Jurkat Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Target cells and effector Jurkat cells were seeded into Nunc™ 96-well plates (Nunc, # 168136) at an effector to target cell (E:T) ratio of 5:1. The 3T3 cell line was used as negative control while EGFR-expressing 3T3 EGFR stable transfected cells were used as the positive control. Antibody test samples diluted in assay media (supplemented RPMI-1640 Glutamax medium; Gibco, # 41966-029) were added into appropriate wells. After an overnight co-culture period at 37°C, the plates were centrifuged and cell supernatants were collected for ELISA analysis. The effector cells were harvested and stained with anti-CD69 FITC antibody, diluted 1:100 (Biolegend, #104506), and anti-HLA class I APC antibody, diluted 1:100 (Biolegend, # 311410) for 30 min at 4°C. Cells were washed twice in PBS + 1% FBS and resuspended in 200 μL of 7-AAD viability dye diluted 1:200 (Invitrogen, #A1310). Samples were run on a Novocyte flow cytometer (ACEA Biosc Inc.). Data was analysed using FlowJo version 10 software (FlowJo, LLC).
+ Open protocol
+ Expand
9

Antibody-Dependent Cell Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Target cells were seeded overnight into Nunc™ 96-well plates (Nunc, #161093). A431, HT-29 and MCF7 cells lines, which express the targeted antigen EGFR, were used as positive cell lines while a CHO cell line was used as a negative control cell line. After 24 h of incubation, antibody test samples diluted in assay media (supplemented RPMI-1640 Glutamax medium; Gibco, # 32404-014) and freshly isolated effector cells PBMC (E:T = 5:1) were added into appropriate wells. After 48 h of co-culture, a final concentration of 1% Triton X-100 (Sigma-Aldrich, #T8787) solution was added into high control wells to obtain maximal cell lysis. Target cells incubated with effector PBMC only were used as the low control. The plates were centrifuged and cell supernatants were collected for cytotoxicity analysis using the LDH cytotoxicity detection kit (Takarabio, #MK401) following the manufacturer’s protocol. 100 µL of cell supernatant was added to 100 µL of reaction mixture, which was prepared according to the manual and incubated for 10–15 min at RT. Absorbance was measured at 492 nm (600 nm as reference wavelength) on a Clariostar plate reader (BMG Labtech). Data was analysed in GraphPad Prism v. 8. Cytotoxicity was calculated following the equation, Cytotoxicity (%) = ((Experiment value − Low control) / (High control − Low control)) x 100.
+ Open protocol
+ Expand
10

Pituitary Dissociation and Immune Depletion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole pituitaries were dissected from wild-type C57BL/6 female mice at 9–10 weeks of age. Whole pituitaries were isolated into ice-cold PBS and then dispersed by incubation with 0.25% collagenase Type IV and 0.25% trypsin–EDTA (1x) (Life Technologies) as previously described (23 (link)). For immune depletion studies, dispersed pituitary was divided in half, with one half being subjected to depletion of total CD45+ immune cells using Miltenyi Biotech anti-C45 micro beads according to protocol. The cells (dispersed pituitary or immune cell depleted pituitary) were plated on poly-l-lysine (Sigma-Aldrich Inc.) coated Nunc 96-well plates (Thermo Fisher Scientific) at a density of 1.5 × 106 cells per cm2. The cells were cultured for 24 h at 37°C and 5% CO2 in high-glucose HEPES-buffered DMEM with 10% FBS prior to experimentation. After pituitary cultures equilibrated they were treated serum starved for 16 hrs, followed by a change in media and 30 min treatment with or without GnRH.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!